DarioHealth Corp. (DRIO) income statement
DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3098% below fair value
$1.44−0.02 (-1.37%)
Close on Nov 19, 2026Market cap $14.11MP/E 0.4Yield –
DarioHealth Corp. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 58.2%
- Operating margin
- -151.6%
- Net margin
- -169.9%
- Return on equity, FY2025
- -59.6%
Financial strength
- Current ratio
- 2.31
- Debt to equity
- 0.56
- Debt to assets
- 32.2%
- Cash to current liabilities
- 69.3%
Valuation
- P/E ratio
- 0.4
- Price to sales
- 0.67
- Price to book
- 0.26
- Dividend yield
- –
See a number that looks wrong?